Featured Research

from universities, journals, and other organizations

Majority of older breast cancer patients use hormone treatment

Date:
June 16, 2014
Source:
Georgetown University Medical Center
Summary:
Women 65 years of age and older comprise about half of patients with breast cancer. Some studies suggest this group initiates therapy less often and discontinues treatment more frequently than younger or middle aged women. 'We found a more positive picture of use,' says the study author. Only 14 percent of the 65- to 91-year-olds in the study didn't start treatment. Non-white women are much more likely to not have therapy.

One of the most comprehensive looks at the use of hormone therapy in women over 65 with non-metastatic breast cancer found some welcome news. Except for frail patients, most participants in the large study complied with their oncologists' recommendations to treat their estrogen-positive breast cancer with hormone therapy -- either an aromatase inhibitor or tamoxifen. These drugs prevent tumors from using estrogen to fuel growth.

Related Articles


But the study, reported online June 16th in the Journal of Clinical Oncology, also found that non-white women were much more likely to not have therapy. "Women 65 years of age and older comprise about half of patients with breast cancer, but some studies have suggested this group initiates therapy less often and discontinues treatment more frequently than younger or middle aged women," says the study's lead author, Vanessa B. Sheppard, PhD, associate professor of oncology and assistant director of health disparities research at Georgetown Lombardi Comprehensive Cancer Center.

"We found a more positive picture of use -- although more than half of patients discontinued use before the five years of recommended treatment, non-initiation of starting treatment was only 14 percent," she says. "This is reassuring, as it's important for women to give themselves a chance for the best outcome possible, regardless of their age."

The seven-year study was conducted at 78 institutions and clinics in the U.S., enrolling 1,062 elderly women ages 65 to 91 with locally invasive cancer that had not spread. Women in the study judged to be frail or even "prefrail" may well be justified in not starting treatment for their breast cancer compare to women who are more robust or less frail, she says. "It may be that these women, with the concurrence of their physicians, felt they would not live long enough to benefit from the therapy given competing health conditions, and they also may have wanted to avoid any toxicities from treatment," Dr. Sheppard says.

Researchers also found that the discontinuation rate (stopping therapy before five years) was 51.5 percent and that the risk of discontinuation was higher with increasing age and lower for advanced stages of the disease. "This rate of discontinuation is about the same seen in some other studies," she says.


Story Source:

The above story is based on materials provided by Georgetown University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. V. B. Sheppard, L. A. Faul, G. Luta, J. D. Clapp, R. L. Yung, J. H.-y. Wang, G. Kimmick, C. Isaacs, M. Tallarico, W. T. Barry, B. N. Pitcher, C. Hudis, E. P. Winer, H. J. Cohen, H. B. Muss, A. Hurria, J. S. Mandelblatt. Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901. Journal of Clinical Oncology, 2014; DOI: 10.1200/JCO.2013.51.7367

Cite This Page:

Georgetown University Medical Center. "Majority of older breast cancer patients use hormone treatment." ScienceDaily. ScienceDaily, 16 June 2014. <www.sciencedaily.com/releases/2014/06/140616204401.htm>.
Georgetown University Medical Center. (2014, June 16). Majority of older breast cancer patients use hormone treatment. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/06/140616204401.htm
Georgetown University Medical Center. "Majority of older breast cancer patients use hormone treatment." ScienceDaily. www.sciencedaily.com/releases/2014/06/140616204401.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins